Bernard Camins, MD

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:18

Article:39

Review Article:3

Comment/Debate:2

Letter:4

Editorial:1

Chapter:1

Selected Publications

• Impact of Pharmacist-Led Multidisciplinary Team to Attain Targeted Vancomycin Area under the Curved Monitoring in a Tertiary Care Center in Thailand
• The role of the clinical pharmacist in antimicrobial stewardship in Asia: A review
• What are the considerations for the treatment of multidrug resistant Acinetobacter baumannii infections?
• Perioperative Interventions to Reduce Surgical Site Infections: A Review
• Factors associated with sars-cov-2 infection in physician trainees in new york city during the first covid-19 wave
• Utilizing technology to enhance screening for highly infectious diseases
• Predictors of Hospital-Acquired Clostridioides difficile Infection: A Systematic Review
• Postpartum Fusobacterium gonidiaformans bacteremia
• Reply to Tascini et al
• Infectious diseases consultation is associated with decreased mortality in enterococcal bloodstream infections

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Camins during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.